| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/07/2009 | EP2010531A1 Spirocyclic cyclohexane derivative with analgesic properties |
| 01/07/2009 | EP2010526A1 Benzimidazole 5-sulfonamide derivatives as cannabinoid 1 (cb1) receptor ligands |
| 01/07/2009 | EP2010518A1 Azabicyclo [3. 1. o] hexane derivatives as modulators of dopamine d3 receptors |
| 01/07/2009 | EP2010509A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives as potassium channel openers |
| 01/07/2009 | EP2010508A1 Thiazol-guanidine derivatives useful as a (beta)- related pathologies |
| 01/07/2009 | EP2010499A1 Pharmaceutical compositions of oxcarbazepine with a median particle size of 15 to 30 microns |
| 01/07/2009 | EP2010208A1 Amylin and amylin agonists for treating psychiatric diseases and disorders |
| 01/07/2009 | EP2009992A2 Il-8 receptor antagonists |
| 01/07/2009 | EP1858900B1 Fused thiazole derivatives having affinity for the histamine h3 receptor |
| 01/07/2009 | EP1851234B1 Substituted propane phosphinic acid esters |
| 01/07/2009 | EP1824472B1 Use of acetyl l-carnitine for the treatment of fibromyalgic syndrome |
| 01/07/2009 | EP1771415B1 2- (1h-indolylsulfanyl) -aryl amine derivatives for use in the treatment of affective disorders, pain, adhd and stress urinary incontinence |
| 01/07/2009 | EP1727799B1 Novel alkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products |
| 01/07/2009 | EP1711230B1 Use of epothilones in the treatment of neuronal connectivity defects such as schizophrenia and autism |
| 01/07/2009 | EP1635843B1 Therapy comprising dienogest for hormone replacement and depression |
| 01/07/2009 | EP1501531B1 Method for treating anxiety in older subjects |
| 01/07/2009 | EP1499291B1 Methods and dosage forms for controlled delivery of oxycodone |
| 01/07/2009 | EP1478389B1 Treatment for diseases of the eye |
| 01/07/2009 | EP1474434B1 The eaat2 promoter and uses thereof |
| 01/07/2009 | EP1456196B1 Benzothiophenes as adenosine receptor modulators |
| 01/07/2009 | EP1425277B1 Urea-compounds active as vanilloid receptor antagonists for the treatment of pain |
| 01/07/2009 | EP1392662B1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments |
| 01/07/2009 | EP1357909B1 Il-8 receptor antagonists |
| 01/07/2009 | EP1246835B1 Substituted sapogenins and their use |
| 01/07/2009 | EP1223973B1 Method of expressing antigens on the surface of antigen presenting cells by photochemical internalization |
| 01/07/2009 | EP1204665B1 Chemokine receptor antagonists and methods of use therefor |
| 01/07/2009 | EP1170005B1 Use of sesquiterpene alcohol for regulating the autonomic nervous system |
| 01/07/2009 | EP1115874B1 Alzheimer's disease secretase |
| 01/07/2009 | EP0662827B2 Diagnostic methods and pharmaceutical compositions based on notch proteins and nucleic acids |
| 01/07/2009 | CN201175155Y Traditional Chinese medicine health-care bed cushion |
| 01/07/2009 | CN101341154A Thienopyridine derivatives as modulators of metabotropic glutamate receptors |
| 01/07/2009 | CN101341153A New compounds |
| 01/07/2009 | CN101341152A New compounds |
| 01/07/2009 | CN101341140A Benzochromene derivatives for use in liquid crystal media and as therapeutic active substances |
| 01/07/2009 | CN101341127A 4,5-dihydro- (1H)-pyrazole derivatives as cannabinoid CB1 receptor modulators |
| 01/07/2009 | CN101341125A New phenanthridine derivatives as bradykinin antagonists |
| 01/07/2009 | CN101340908A Compositions and methods for treating cns disorders |
| 01/07/2009 | CN101337956A Scutellarein carbamate derivates, preparation method and application thereof |
| 01/07/2009 | CN101337871A Indandione compound |
| 01/07/2009 | CN101337049A Production method of pills for treating rheumatoid, rheumatism and infantile paralysis |
| 01/07/2009 | CN101337034A Oral traditional Chinese preparation for treating craniocerebral injury syndrome and preparation method thereof |
| 01/07/2009 | CN101337019A Oral traditional Chinese medicine formulation for treating herpes zoster post herpetic neuralgia and preparation method thereof |
| 01/07/2009 | CN101337012A External traditional Chinese medicine formulation for treating herpes zoster post herpetic neuralgia and preparation method thereof |
| 01/07/2009 | CN101337003A Traditional Chinese medicine preparation for treating lumbar intervertebral disc protrusion and sciatica |
| 01/07/2009 | CN101337002A Traditional Chinese medicine capsule for treating rheumatism and nervous system |
| 01/07/2009 | CN101336989A New use of Chinese goldthread detoxication decoction in treating parkinsonism and parkinsonian syndrome |
| 01/07/2009 | CN101336987A Preparation method of total flavone of Hovenia dulcisThunb |
| 01/07/2009 | CN101336973A Analgesic and anticancer traditional Chinese medicine preparation and preparation method thereof |
| 01/07/2009 | CN101336927A Use of morroniside in preventing or treating brain fundamental sickness |
| 01/07/2009 | CN101336913A Compositions having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction |
| 01/07/2009 | CN101336718A Compound milk preparation for benefiting brain and enhancing intelligence and activating children brain cell |
| 01/07/2009 | CN101336717A Compound soy-milk preparation for speeding the cycle of loosing and closing children skull |
| 01/07/2009 | CN101336656A Brain nourishing, intelligence benefiting and healthy noodle capable of activating brain cell and production method thereof |
| 01/07/2009 | CN100448893C Humanized antibodies that recognize beta amyloid peptide |
| 01/07/2009 | CN100448875C Substituted 1-piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 01/07/2009 | CN100448874C N-aroyl cyclic amines |
| 01/07/2009 | CN100448870C 2-aminoquinoline derivative |
| 01/07/2009 | CN100448867C 1,2,4-triaminobenzenderivater nyttige for behandling AV forstyrrelser i sentralnervesystemet |
| 01/07/2009 | CN100448861C Dihydrobenzofuranyl alkanamines and pharmaceutical compositions containing them |
| 01/07/2009 | CN100448852C Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 01/07/2009 | CN100448848C New polysubstituted 1, 1pyridylaminocyclopropanamine compounds,a process for their preparation and pharmaceutical compositions containing them |
| 01/07/2009 | CN100448481C Novel use of xCT protein and its encoding gene |
| 01/07/2009 | CN100448475C Dry concentrate of yellow wine and preparation method thereof |
| 01/07/2009 | CN100448456C Chinese pilose spore concentrated oral liquid |
| 01/07/2009 | CN100448451C Nutritional compositions with contain slightly negatively charged, non-digestible polysaccharides and use thereof for reducing transport through tight junctions |
| 01/07/2009 | CN100448449C [[2-(amino-3,4-dioxo-1-cyclobuten-1-yl)amino]alkyl]-acid derivatives for the treatment of pain |
| 01/07/2009 | CN100448446C Buckthorn extract, its preparing method and use in pharmaceutical process |
| 01/07/2009 | CN100448440C Protective solution for preventing local ischemic damage |
| 01/07/2009 | CN100448439C Pharmaceutical compositions for headache, migraine, nausea and emesis |
| 01/07/2009 | CN100448432C Method for preparing nimodipine dispersible tablet with high dissolution |
| 01/07/2009 | CN100448430C Oil-in-water type nanometer grassleaved sweetflag oil emulsion oral liquid and its prepn process |
| 01/06/2009 | US7473779 e.g. 2-amino-N-(4-{[amino(2-thienyl)methylidene]amino}phenethyl)-5-methoxybenzamide; nitric oxide NO-synthase enzymes inhibitor; selective or non selective traps for reactive oxygen species; antiproliferative, antiinflammatory agent |
| 01/06/2009 | US7473698 Secondary amino anilinic piperidines as MCH1 antagonists and uses thereof |
| 01/06/2009 | US7473697 2-Oxo-piperidinyl- and 2-oxo-azepanyl alkanoic acid derivatives for the treatment of epilepsy and other neurological disorders |
| 01/06/2009 | US7473692 Sulfonamide derivatives as D3-receptor ligands |
| 01/06/2009 | US7473689 Short-acting benzodiazepines |
| 01/06/2009 | US7473679 Treatments employing neuronal exocytosis-inhibiting peptides |
| 01/06/2009 | US7473431 Injectable methadone, methadone and naltrexone, or buprenorphine and naltrexone microparticle compositions and their use in reducing consumption of abused substances |
| 01/06/2009 | US7473420 Processing adipose tissue to deliver a concentrated amount of stem cells in a closed system so that the stem cells are not exposed to external environment by use of a pre-assembled, linked set of closed, sterile containers and tubing allowing for transfer of tissue and fluid elements within a closed path |
| 01/06/2009 | CA2425812C Treatment of oppositional defiant disorder and conduct disorder with 5-amino-4,5,6,7-tetrahydro-4-oxyindolones |
| 01/06/2009 | CA2421267C Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof |
| 01/06/2009 | CA2414095C Novel compounds |
| 01/06/2009 | CA2387058C Injection vehicle for polymer-based formulations |
| 01/06/2009 | CA2369504C Pyrazole compositions useful as inhibitors of erk |
| 01/06/2009 | CA2348084C Crystallisation using supercritical or subcritical fluids |
| 01/06/2009 | CA2293575C Controlled release microencapsulated ngf formulation |
| 01/06/2009 | CA2288533C New 4-substituted piperidines |
| 01/06/2009 | CA2264582C Sulfonyl fluorides for the treatment of alzheimer's disease |
| 01/06/2009 | CA2235350C Use of creatine or creatine analogs for the treatment of diseases of the nervous system |
| 01/06/2009 | CA2227851C Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives |
| 01/05/2009 | CA2593020A1 Medicament compounds |
| 01/01/2009 | US20090005568 Substituted 2-aminothiazoles for treating neurodegenerative diseases |
| 01/01/2009 | US20090005459 NMDA receptor antagonists and their use in inhibiting abnormal hyperphosphorylation of microtubule associated protein tau |
| 01/01/2009 | US20090005458 Preferably in sustained release dosage form; Side effect reduction compared to conventional analgesics |
| 01/01/2009 | US20090005457 Solid forms comprising (-)-O-desmethylvenlafaxine and uses thereof |
| 01/01/2009 | US20090005456 Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors |
| 01/01/2009 | US20090005455 (R,S)-1-[2-oxido-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-cyclohexanol (venlafaxine N-oxide); depression, major depressive disorder, generalized anxiety disorder, obsessive compulsive disorder, social anxiety disorder, panic disorder, general depressive disorders, diabetic neuropathy, migraine |
| 01/01/2009 | US20090005446 Prophylactic Antistress Agent |
| 01/01/2009 | US20090005444 Use of propofol prodrugs for treating alcohol withdrawal, central pain, anxiety or pruritus |
| 01/01/2009 | US20090005442 Carbamate compounds for use in preventing or treating neurodegenerative disorders |